The Anti-Inflammatory Agent Bindarit Attenuates the Impairment of Neural Development through Suppression of Microglial Activation in a Neonatal Hydrocephalus Mouse Model

Abstract

Neonatal hydrocephalus presents with various degrees of neuroinflammation and long-term neurologic deficits in surgically treated patients, provoking a need for additional medical treatment. We previously reported elevated neuroinflammation and severe periventricular white matter damage in the progressive hydrocephalus (prh) mutant which contains a point mutation in the Ccdc39 gene, causing loss of cilia-mediated unidirectional CSF flow. In this study, we identified cortical neuropil maturation defects such as impaired excitatory synapse maturation and loss of homeostatic microglia, and swimming locomotor defects in early postnatal prh mutant mice. Strikingly, systemic application of the anti-inflammatory small molecule bindarit significantly supports healthy postnatal cerebral cortical development in the prh mutant. While bindarit only mildly reduced the ventricular volume, it significantly improved the edematous appearance and myelination of the corpus callosum. Moreover, the treatment attenuated thinning in cortical Layers II-IV, excitatory synapse formation, and interneuron morphogenesis, by supporting the ramified-shaped homeostatic microglia from excessive cell death. Also, the therapeutic effect led to the alleviation of a spastic locomotor phenotype of the mutant. We found that microglia, but not peripheral monocytes, contribute to amoeboid-shaped activated myeloid cells in prh mutants' corpus callosum and the proinflammatory cytokines expression. Bindarit blocks nuclear factor (NF)-kB activation and its downstream proinflammatory cytokines, including monocyte chemoattractant protein-1, in the prh mutant. Collectively, we revealed that amelioration of neuroinflammation is crucial for white matter and neuronal maturation in neonatal hydrocephalus. Future studies of bindarit treatment combined with CSF diversion surgery may provide long-term benefits supporting neuronal development in neonatal hydrocephalus.

Epigenetic erosion of H4K20me1 induced by inflammation drives aged stem cell ferroptosis.

“…Improvement in muscle regeneration was not observed in adult mice, despite the presence of fewer circulatory monocytes (Figure S12A-F). It was also not detrimental, possibly bene ting from circumstances with chronic in ammation only, as previously reported [52][53][54] .…”

CCL2 is required for initiation but not persistence of HIV infection mediated neurocognitive disease in mice

“…To test the effects of CCL2 upon initiation of HIV brain disease by an alternate approach, we employed the compound bindarit that inhibits transcription of CCL2 through interference with NFκB activation at the CCL2 promoter 35 . In mice, bindarit blocks expression of CCL2 RNA and protein and prevents inflammatory monocyte entry into the brain 46 and it also prevents pathological microglia activation during impaired neonatal brain development 47 . C57BL/6 mice were pretreated with bindarit 1 day before EcoHIV infection by IP injection and then treated daily through RAWM testing starting on Day 25 until euthanasia on Day 32 (Fig.…”

A year in review: brain barriers and brain fluids research in 2022

“…The mutation also causes periventricular white matter injury and neuroinflammation. Iwasawa et al [ 126 ] found that an anti-inflammatory agent, Bindarit, improved cortical development and reduced white matter injury in these mice while having only a mild effect on ventricular volume.…”